Efficacy and safety of ezetimibe coadministered with pravastatin in patients with primary hypercholesterolemia: a prospective, randomized, double-blind trial

2003273 citationsJournal Articlebronze Open Access

Authors

Abstract

When coadministered with pravastatin, ezetimibe provided significant incremental reductions in LDL-C and TG and was well tolerated with a safety profile similar to pravastatin alone.

Topics & Keywords

Lipoproteins and Cardiovascular Health Pharmaceutical Economics and Policy

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: European Heart Journal

Volume 24, Issue 8, pp. 717-728

DOI: 10.1016/s0195-668x(02)00803-5

Field-Weighted Citation Impact: 30.49